; (B) provide training and technical assistance to States, localities, and Indian tribes to carrying out any such activity; and (C) award grants to States, localities, and tribes for the purpose of carrying out any such activity. (2) Prevention activities A prevention activity described in this paragraph is an activity to improve the efficiency and use of a new or currently operating prescription drug monitoring program— (A) encouraging all authorized users (as specified by the State or other entity) to register with and use the program; (B) enabling such users to access any data updates in as close to real-time as practicable; (C) providing for a mechanism for the program to notify authorized users of any potential misuse or abuse of controlled substances and any detection of inappropriate prescribing practices relating to such substances; (D) encouraging the analysis of prescription drug monitoring data for purposes of providing de-identified, aggregate reports based on such analysis to State public health agencies, State licensing boards, and other appropriate State agencies, as permitted under applicable Federal and State law and the policies of the prescription drug monitoring program and not containing any protected health information, to prevent inappropriate prescribing, drug diversion, or abuse and misuse of controlled substances, and to facilitate better coordination among agencies; (E) enhancing interoperability between the program and any health information technology (including certified health information technology), including by integrating program data into such technology; (F) updating program capabilities to respond to technological innovation for purposes of appropriately addressing the occurrence and evolution of controlled substance overdoses